Document is current

Any future updates will be listed below

Self-adjuvanted RNActive® vaccines provide a promising platform for combination therapies with checkpoint inhibitors

Crossref DOI link: https://doi.org/10.1186/2051-1426-2-S3-P109

Published Online: 2014-11-06

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark